| (P1416) |
Effect of different surface microstructures on stent endothelialisation and thrombogenicity |
|
I. Cicha, C. Lutter, M. Nothhaft, A. Rzany, S. Achenbach, C. Garlichs (Erlangen) |
| (P1417) |
Use of ABSORB everolimus-eluting bioresorbable vascular scaffold systems in acute coronary syndrome patients. |
|
T. Gori, H. U. Hink, Z. Qu, T. Münzel (Mainz) |
| (P1418) |
Long term outcome after rotablation for bail-out in severely calcified coronary lesions |
|
M. Ferenc, H. J. Büttner, M. Gick, F.-J. Neumann (Bad Krozingen) |
| (P1419) |
The Paclitaxel-eluting PTCA-Balloon catheter in combination with a cobalt-chromium stent to treat coronary artery disease in a real world scenario - the 12-month outcome |
|
M. Unverdorben, U. Kaul, R. Degenhardt, A. Seth, V. K. Bahl, S. M. S. Hiremath (Rotenburg a.d. Fulda; New Delhi, Pune, IN) |
| (P1420) |
Five-year clinical follow-up of a randomized comparison between a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus |
|
T. Stiermaier, A. Heinz, D. Schloma, G. C. Schuler, H. Thiele, S. Desch (Leipzig) |
| (P1421) |
Everolimus versus Paclitaxel eluting stent in Patient with ST Elevation Myocardial Infarction – a multicentre experience |
|
S. Markovic, R. Birkemeyer, C. Kugler, P. Bernhardt, A. Imhof, J. Spieß, W. Rottbauer, J. Wöhrle (Ulm, Rostock) |
| (P1422) |
Long-Term Outcomes of Biodegradable Polymer Sirolimus-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents in Patients with Diabetes |
|
L. King, A. de Waha, R. Byrne, A. Kastrati, S. Windecker (München; Bern, CH) |
| (P1423) |
Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents |
|
Y. Seivani, M. Abdel-Wahab, I. Akin, G. Richardt, D. Sulimov, M. El-Mawardy, R. Tölg (Bad Segeberg, Rostock) |
| (P1424) |
Predictors of therapy failure after treatment of Instent-Restenosis of Drug-Eluting Stents with Drug Coated Balloons |
|
H. Rittger, M. Waliszewski, J. Wöhrle, C. Schlundt, C. Garlichs, J. Brachmann, S. Achenbach (Erlangen, Berlin, Ulm, Coburg) |
| (P1425) |
Cost-Effectiveness of Paclitaxel-Coated Balloon Angioplasty in Patients with Drug-Eluting Stent Restenosis |
|
M. Dorenkamp, A. Leber, J. Boldt, C. Sohns, L.-H. Boldt, M. Roser, W. Haverkamp, K. Bonaventura (Berlin, München, Göttingen, Potsdam) |
| (P1426) |
Baseline or on-treatment platelet reactivity as optimal predictor for long-term clinical outcome of patients undergoing coronary intervention |
|
W. Hochholzer, D. Trenk, C. M. Valina, C. Stratz, T. Nührenberg, H. J. Büttner, F.-J. Neumann (Bad Krozingen) |
| (P1427) |
Sirolimus-Eluting versus Paclitaxel-Eluting Stents in Diabetic Patients with in “limus” Stent Restenosis, Results from the ISAR DESIRE 2 Trial |
|
S. Kufner, R. Byrne, A. de Waha, S. Schulz, K. A. Fiedler, A. Kastrati (München) |